A deep convolutional neural network-based automatic delineation strategy for multiple brain metastases stereotactic radiosurgery

Liu, Yan; Stojadinovic, Strahinja; Hrycushko, Brian; Wardak, Zabi; Lau, Steven; Lu, Weiguo; Yan, Yulong; Jiang, Steve B.; Zhen, Xin; Timmerman, Robert; Nedzi, Lucien; Gu, Xuejun
October 2017
PLoS ONE;10/6/2017, Vol. 12 Issue 10, p1
Academic Journal
Accurate and automatic brain metastases target delineation is a key step for efficient and effective stereotactic radiosurgery (SRS) treatment planning. In this work, we developed a deep learning convolutional neural network (CNN) algorithm for segmenting brain metastases on contrast-enhanced T1-weighted magnetic resonance imaging (MRI) datasets. We integrated the CNN-based algorithm into an automatic brain metastases segmentation workflow and validated on both Multimodal Brain Tumor Image Segmentation challenge (BRATS) data and clinical patients' data. Validation on BRATS data yielded average DICE coefficients (DCs) of 0.75±0.07 in the tumor core and 0.81±0.04 in the enhancing tumor, which outperformed most techniques in the 2015 BRATS challenge. Segmentation results of patient cases showed an average of DCs 0.67±0.03 and achieved an area under the receiver operating characteristic curve of 0.98±0.01. The developed automatic segmentation strategy surpasses current benchmark levels and offers a promising tool for SRS treatment planning for multiple brain metastases.


Related Articles

  • WBRT plus SRS for Tumors in Eloquent Locations: But Why Give the WBRT? Sahgal, Arjun // Canadian Journal of Neurological Sciences;Sep2015, Vol. 42 Issue 5, p283 

    The author reflects on the use of whole brain radiation (WBRT) plus stereotactic radiosurgery (SRS) to treat tumors in eloquent locations. Topics include the disapproval of the American Society for Radiation Oncology for the use of WBRT, support of SRS alone by the National Comprehensive Cancer...

  • Efficacy and Safety of Fractionated Stereotactic Radiosurgery for Large Brain Metastases. Won Joo Jeong; Jae Hong Park; Eun Jung Lee; Jeong Hoon Kim; Chang Jin Kim; Young Hyun Cho // Journal of Korean Neurosurgical Society;Sep2015, Vol. 58 Issue 3, p217 

    Objective: To investigate the efficacy and safety of fractionated stereotactic radiosurgery for large brain metastases (BMs). Methods: Between June 2011 and December 2013, a total of 38 large BMs >3.0 cm in 37 patients were treated with fractionated Cyberknife radiosurgery. These patients...

  • Lymphopenia predicts response to stereotactic radiosurgery in lung cancer patients with brain metastases. Li, Yuping D.; Lamano, Jason B.; Kaur, Gurvinder; Lamano, Jonathan B.; Veliceasa, Dorina; Biyashev, Dauren; Kruser, Timothy; Bloch, Orin // Journal of Neuro-Oncology;Jun2019, Vol. 143 Issue 2, p337 

    Background: Stereotactic radiosurgery (SRS) can enhance immune activation and improve disease control through stimulation of anti-tumor immunity. However, patients with cancer receiving chemotherapy are often immunosuppressed, which may impact the efficacy of SRS. Here we investigate the...

  • Health-related quality of life in adult patients with brain metastases after stereotactic radiosurgery: a systematic, narrative review. Verhaak, Eline; Gehring, Karin; Hanssens, Patrick E. J.; Aaronson, Neil K.; Sitskoorn, Margriet M. // Supportive Care in Cancer;Feb2020, Vol. 28 Issue 2, p473 

    Purpose: A growing number of patients with brain metastases (BM) are being treated with stereotactic radiosurgery (SRS), and the importance of evaluating the impact of SRS on the health-related quality of life (HRQoL) in these patients has been increasingly acknowledged. This...

  • Control of brain metastases from radioresistant tumors treated by stereotactic radiosurgery. Yaeh, Andrew; Nanda, Tavish; Jani, Ashish; Rozenblat, Tzlil; Qureshi, Yasir; Saad, Shumaila; Lesser, Jeraldine; Lassman, Andrew; Isaacson, Steven; Sisti, Michael; Bruce, Jeffrey; McKhann, Guy; Wang, Tony // Journal of Neuro-Oncology;Sep2015, Vol. 124 Issue 3, p507 

    Renal cell carcinoma, sarcoma, and melanoma are considered to be 'radioresistant' tumor histologies. Brain metastases (BM) from these tumors are considered unlikely to be controlled using the relatively low doses used in whole brain radiotherapy (WBRT). Our objective was to analyze the efficacy...

  • Brain metastases in melanoma require multidisciplinary approach. Leiser, Mark // Hem/Onc Today;6/10/2014, Vol. 15 Issue 11, p18 

    The article focuses on the need for a multidisciplinary approach in addressing the complications of brain metastases in melanoma and mentions topics including leptomeningeal disease, stereotactic radiosurgery, and ipilimumab.

  • Fractionated stereotactic radiosurgery for intracranial metastases: tumor control. Katz, J. S.; Kushnirsky, M.; Knisely, J.; Schulder, M.; Ghaly, M. // Journal of Radiosurgery & SBRT;2013 Supplement 2.1, Vol. 2, p18 

    Purpose: Fractionated SRS may confer radiobiologic treatment advantages in the eradication of metastatic brain tumors. We compared the results of single and fractionated SRS for patients with metastatic tumors. Methods: We reviewed all patients from our institution who were treated with SRS for...

  • Early determination of metastasis response to high dose radiotherapy using advanced MRI imaging. Jakubovic, R.; Sahgal, A.; Milwid, R.; Aviv, R. I. // Journal of Radiosurgery & SBRT;2013 Supplement 2.1, Vol. 2, p113 

    Purpose: Stereotactic radiosurgery (SRS) and whole brain radiation therapy (WBRT) are frequently employed in cerebral metastasis treatment. Dynamic susceptibility (DSC) and dynamic contrast enhancement (DCE) have potential to distinguish very early tumor response prior to structural imaging...

  • Factors contributing to motor function improvement or deterioration following radiosurgery for motor-region metastases. Luther, N.; Kondziolka, D.; Kano, H.; Moussavi, H.; Flickinger, J.; Lunsford, L. D. // Journal of Radiosurgery & SBRT;2013 Supplement 2.1, Vol. 2, p53 

    Introduction: We sought to better define factors that affect the clinical response of patients who underwent stereotactic radiosurgery (SRS) for brain metastases located in the region of the motor cortex. Methods: We performed a retrospective analysis of 2026 brain metastasis patients who...

  • Validation of T1/T2 mismatch for accurate differentiation between radiation injury and recurrence of metastatic brain tumor after gamma knife surgery. -Comparison with methionine pet-. M. Inaji; T. Nariai; Y. Tanaka; K. Ishiwata; K. Ishii; T. Maehara; M. Yamamoto // Journal of Radiosurgery & SBRT;2013 Supplement 2.1, Vol. 2, p142 

    Purpose: Stereotactic radiosurgery (SRS) is an effective primary treatment for small volume metastatic brain tumors. Radiation induced necrosis is majorcomplication of SRS, early diagnosis and adequate treatment is important to avoid neurological deterioration . However, it is sometimes...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics